Clinical Trial Update: 21-day Double-blind Trial of Albendazole in Adults With Loa Loa Microfilaremia [Phase 3]

View source ↗

Summary

A Phase 3 double-blind trial evaluating Albendazole in adults with Loa loa microfilaremia is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Loa Loa Infection

Drugs mentioned

• Albendazole (ALBENDAZOLE)

Snippet

Sponsor: Programme National de Lutte contre l'Onchocercose, Republic of the Congo | Conditions: Loiasis With Positive Blood Microfilaremia, Loiasis | Phase 3 | Status: NOT_YET_RECRUITING